EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 4.0

Protocol for screening inhibitors of the fungal sphingolipid-metabolizing enzyme ceramide synthase

Andy Zhong, Deveney Dasilva, Nivea Pereira de Sa, Jeehyun Karen You, Maurizio Del Poeta

STAR Protocols · 2025-09 · 6 (3) · 104078

DOI: 10.1016/j.xpro.2025.104078 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift STAR Protocols, 2025-09. Verfasst von Andy Zhong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794, USA. Hauptthemen laut MEDLINE: Oxidoreductases, Sphingolipids, Saccharomyces cerevisiae, Enzyme Inhibitors. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: US Department of Defense, National Institutes of Health, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungal sphingolipids have emerged as potent antifungal targets based on cumulative evidence demonstrating that fungal sphingolipid metabolism is essential to the virulence of pathogenic fungi. Here, we present a protocol to screen for inhibitors of the sphingolipid-metabolizing enzyme ceramide synthase. We describe steps for harvesting microsomes from Saccharomyces cerevisiae, performing in vitro reactions, and performing lipid extractions. We then detail the use of a high-performance liquid chromatography (HPLC)-based fluorometric assay to screen large chemical libraries for ceramide synthase inhibitors. For complete details on the use and execution of this protocol, please refer to Dasilva et al.1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxidoreductasesSphingolipidsSaccharomyces cerevisiaeEnzyme InhibitorsAntifungal AgentsChromatography, High Pressure LiquidMicrosomesDrug Evaluation, Preclinical

Stichwörter der Autor:innen

Cell-based AssaysHigh-Throughput ScreeningMicrobiology

Substanzen

OxidoreductasesSphingolipidsdihydroceramide desaturaseEnzyme InhibitorsAntifungal Agents

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794, USA.
  • Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794, USA; Veterans Affairs Medical Center, Northport, NY, USA; Division of Infectious Diseases, School of Medicine, Stony Brook Univer…

Förderung

  • US Department of Defense
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases
  • US Department of Veterans Affairs
  • Stony Brook University

Zitieren

APA

Zhong, A., Dasilva, D., Pereira de Sa, N., You, J. K., & Del Poeta, M. (2025). Protocol for screening inhibitors of the fungal sphingolipid-metabolizing enzyme ceramide synthase. STAR Protocols, 6(3), 104078. https://doi.org/10.1016/j.xpro.2025.104078

Vancouver

Zhong A, Dasilva D, Pereira de Sa N, You JK, Del Poeta M. Protocol for screening inhibitors of the fungal sphingolipid-metabolizing enzyme ceramide synthase. STAR Protocols. 2025;6(3):104078. doi:10.1016/j.xpro.2025.104078

BibTeX
@article{Zhong2025,
  author = {Zhong, Andy and Dasilva, Deveney and Pereira de Sa, Nivea and You, Jeehyun Karen and Del Poeta, Maurizio},
  title = {Protocol for screening inhibitors of the fungal sphingolipid-metabolizing enzyme ceramide synthase},
  journal = {STAR Protocols},
  year = {2025},
  volume = {6},
  number = {3},
  pages = {104078},
  doi = {10.1016/j.xpro.2025.104078}
}
Kostenlos starten →